The results showed a lower incidence of hypoglycemia during Ramadan's daily intermittent fasting compared to the pre-Ramadan period, especially in patients taking more recent diabetes medications, such as sodium-glucose transport-2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors (DPP-4i) (SGLT-2i) [25]. This evidence concerns the gene GLP1R and Hypoglycemia.